申请人:Boehringer Ingelheim International GmbH
公开号:US10954215B2
公开(公告)日:2021-03-23
The present invention encompasses compounds of the formula (I) wherein the variables are defined herein which are suitable for the modulation of RORγ and the treatment of diseases related to the modulation of RORγ. The present invention also encompasses processes of making compounds of formula (I) and pharmaceutical preparations containing them.
本发明包括式(I)化合物,其中变量在此定义,该化合物适用于调节 RORγ 和治疗与调节 RORγ 有关的疾病。本发明还包括式(I)化合物的制造工艺和含有它们的药物制剂。